Allergan (AGN) has gone to lengths to protect its patents. Drug makers have every right to protect their intellectual property. They practically have a fiduciary responsibility to their shareholders to do so. However, Allergan’s aggressive tactics have been considered by many to have crossed the line.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,